Small Animal Clinic, University of Veterinary Medicine, Foundation, Bünteweg 9, 30559 Hannover, Germany.
J Nanobiotechnology. 2013 Oct 10;11:34. doi: 10.1186/1477-3155-11-34.
In orthopaedic surgery, accumulation of agents such as anti-infectives in the bone as target tissue is difficult. The use of magnetic nanoparticles (MNPs) as carriers principally enables their accumulation via an externally applied magnetic field. Magnetizable implants are principally able to increase the strength of an externally applied magnetic field to reach also deep-seated parts in the body. Therefore, the integration of bone-addressed therapeutics in MNPs and their accumulation at a magnetic orthopaedic implant could improve the treatment of implant related infections. In this study a martensitic steel platelet as implant placeholder was used to examine its accumulation and retention capacity of MNPs in an in vitro experimental set up considering different experimental frame conditions as magnet quantity and distance to each other, implant thickness and flow velocity.
The magnetic field strength increased to approximately 112% when a martensitic stainless steel platelet was located between the magnet poles. Therewith a significantly higher amount of magnetic nanoparticles could be accumulated in the area of the platelet compared to the sole magnetic field. During flushing of the tube system mimicking the in vivo blood flow, the magnetized platelet was able to retain a higher amount of MNPs without an external magnetic field compared to the set up with no mounted platelet during flushing of the system. Generally, a higher flow velocity led to lower amounts of accumulated MNPs. A higher quantity of magnets and a lower distance between magnets led to a higher magnetic field strength. Albeit not significantly the magnetic field strength tended to increase with thicker platelets.
A martensitic steel platelet significantly improved the attachment of magnetic nanoparticles in an in vitro flow system and therewith indicates the potential of magnetic implant materials in orthopaedic surgery. The use of a remanent magnetic implant material could improve the efficiency of capturing MNPs especially when the external magnetic field is turned off thus facilitating and prolonging the effect. In this way higher drug levels in the target area might be attained resulting in lower inconveniences for the patient.
在矫形外科手术中,抗菌剂等药物在骨骼等靶组织中的积累较为困难。使用磁性纳米颗粒(MNPs)作为载体,主要可以通过外部施加的磁场来实现其积累。可磁化植入物主要能够增强外部施加磁场的强度,从而到达体内深处的部位。因此,将针对骨骼的治疗药物整合到 MNPs 中,并将其在磁性骨科植入物上积累,可以改善与植入物相关的感染的治疗效果。在这项研究中,使用马氏体不锈钢薄片作为植入物的占位符,在不同的实验框架条件下(例如磁铁数量和彼此之间的距离、植入物厚度和流速),在体外实验装置中检查 MNPs 的积累和保留能力。
当马氏体不锈钢薄片位于磁极之间时,磁场强度增加到约 112%。因此,与仅存在磁场的区域相比,可以在薄片区域中积累更多的磁性纳米颗粒。在模拟体内血流的管系统冲洗过程中,与在系统冲洗过程中未安装薄片的情况相比,磁化的薄片能够在没有外部磁场的情况下保留更多的 MNPs。一般来说,较高的流速会导致积累的 MNPs 数量减少。磁铁数量较多和磁铁之间的距离较短会导致磁场强度较高。尽管没有显著差异,但磁场强度似乎会随着薄片厚度的增加而增加。
马氏体不锈钢薄片在体外流动系统中显著改善了磁性纳米颗粒的附着,这表明磁性植入材料在矫形外科手术中的潜力。使用剩余磁性植入材料可以提高捕获 MNPs 的效率,特别是在外部磁场关闭时,从而方便并延长其效果。通过这种方式,可以在靶区获得更高的药物水平,从而降低患者的不便。